Pluri (PLUR) Net Cash Flow (2010 - 2025)
Pluri (PLUR) reported Net Cash Flow of -$2.5 million for Q4 2025, down 163.41% year-over-year from $4.0 million in Q4 2024, and down 61.41% quarter-over-quarter from -$1.6 million in Q3 2025.
Pluri (PLUR) Net Cash Flow (2010 - 2025) Analysis & Trends
Pluri (PLUR) has 16 years of Net Cash Flow data on file, last reported at -$2.5 million in Q4 2025.
- Net Cash Flow for Q4 2025 came in at -$2.5 million, down 163.41% year-over-year; the trailing twelve-month figure through Dec 2025 was -$15.3 million (down 114.83% YoY), and the FY2025 annual result was -$652000.0, down 146.44% from the prior year.
- Net Cash Flow retreated to -$2.5 million in Q4 2025 per PLUR's latest filing, from -$1.6 million in the prior quarter.
- Over five years, Net Cash Flow peaked at $19.6 million in Q2 2021 and troughed at -$16.0 million in Q3 2021.
- A 5-year average of -$1.7 million and a median of -$1.7 million in 2022 frame the typical range for Net Cash Flow.
- On a YoY basis, Net Cash Flow climbed as much as 1387.78% in 2024 and fell as far as 6225.45% in 2024.
- A 5-year view of Net Cash Flow shows it stood at $4.5 million in 2021, then tumbled by 226.03% to -$5.6 million in 2022, then soared by 104.81% to $270000.0 in 2023, then soared by 1387.78% to $4.0 million in 2024, then plunged by 163.41% to -$2.5 million in 2025.
- Business Quant data shows PLUR's Net Cash Flow at -$2.5 million in Q4 2025, -$1.6 million in Q3 2025, and -$2.6 million in Q2 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | NCF (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - | - |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - | - |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - | 2.44 Mn |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn | 625.70 Mn |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - | -2.44 Mn |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - | - |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn | 457.40 Mn |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - | 664,983.53 |
| 10 | Pluri | 21.39 Mn | 21.87 Mn | 86,000.00 | -2.55 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -2.55 Mn |
| Dec 31, 2025 | -2.55 Mn |
| Sep 30, 2025 | -1.58 Mn |
| Sep 30, 2025 | -1.58 Mn |
| Jun 30, 2025 | -2.62 Mn |
| Jun 30, 2025 | -2.62 Mn |
| Mar 31, 2025 | -8.54 Mn |
| Mar 31, 2025 | -8.54 Mn |
| Dec 31, 2024 | 4.02 Mn |
| Dec 31, 2024 | 4.02 Mn |
| Sep 30, 2024 | -3.48 Mn |
| Sep 30, 2024 | -3.48 Mn |
| Jun 30, 2024 | -9.12 Mn |
| Jun 30, 2024 | -9.12 Mn |
| Mar 31, 2024 | 1.47 Mn |
| Mar 31, 2024 | 1.47 Mn |
| Dec 31, 2023 | 270,000.00 |
| Dec 31, 2023 | 270,000.00 |
| Sep 30, 2023 | -55,000.00 |
| Sep 30, 2023 | -55,000.00 |